vs
Side-by-side financial comparison of FEDERAL SIGNAL CORP (FSS) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
FEDERAL SIGNAL CORP is the larger business by last-quarter revenue ($597.1M vs $493.8M, roughly 1.2× Pediatrix Medical Group, Inc.). FEDERAL SIGNAL CORP runs the higher net margin — 10.2% vs 6.8%, a 3.4% gap on every dollar of revenue. On growth, FEDERAL SIGNAL CORP posted the faster year-over-year revenue change (26.5% vs -1.7%). Over the past eight quarters, FEDERAL SIGNAL CORP's revenue compounded faster (18.5% CAGR vs -0.1%).
The Federal Signal Company was an American manufacturer of railway signaling equipment in the early 20th century. It was located in Albany, New York.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
FSS vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $597.1M | $493.8M |
| Net Profit | $60.8M | $33.7M |
| Gross Margin | 28.4% | — |
| Operating Margin | 14.0% | 9.9% |
| Net Margin | 10.2% | 6.8% |
| Revenue YoY | 26.5% | -1.7% |
| Net Profit YoY | 21.6% | 10.5% |
| EPS (diluted) | $0.99 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $597.1M | $493.8M | ||
| Q3 25 | $555.0M | $492.9M | ||
| Q2 25 | $564.6M | $468.8M | ||
| Q1 25 | $463.8M | $458.4M | ||
| Q4 24 | $472.0M | $502.4M | ||
| Q3 24 | $474.2M | $511.2M | ||
| Q2 24 | $490.4M | $504.3M | ||
| Q1 24 | $424.9M | $495.1M |
| Q4 25 | $60.8M | $33.7M | ||
| Q3 25 | $68.1M | $71.7M | ||
| Q2 25 | $71.4M | $39.3M | ||
| Q1 25 | $46.3M | $20.7M | ||
| Q4 24 | $50.0M | $30.5M | ||
| Q3 24 | $53.9M | $19.4M | ||
| Q2 24 | $60.8M | $-153.0M | ||
| Q1 24 | $51.6M | $4.0M |
| Q4 25 | 28.4% | — | ||
| Q3 25 | 29.1% | — | ||
| Q2 25 | 30.0% | — | ||
| Q1 25 | 28.2% | — | ||
| Q4 24 | 28.1% | — | ||
| Q3 24 | 29.6% | — | ||
| Q2 24 | 29.4% | — | ||
| Q1 24 | 27.3% | — |
| Q4 25 | 14.0% | 9.9% | ||
| Q3 25 | 16.9% | 13.8% | ||
| Q2 25 | 17.3% | 12.8% | ||
| Q1 25 | 14.2% | 7.0% | ||
| Q4 24 | 14.9% | 7.8% | ||
| Q3 24 | 16.0% | 6.6% | ||
| Q2 24 | 16.5% | -31.3% | ||
| Q1 24 | 12.8% | 3.2% |
| Q4 25 | 10.2% | 6.8% | ||
| Q3 25 | 12.3% | 14.5% | ||
| Q2 25 | 12.6% | 8.4% | ||
| Q1 25 | 10.0% | 4.5% | ||
| Q4 24 | 10.6% | 6.1% | ||
| Q3 24 | 11.4% | 3.8% | ||
| Q2 24 | 12.4% | -30.3% | ||
| Q1 24 | 12.1% | 0.8% |
| Q4 25 | $0.99 | $0.40 | ||
| Q3 25 | $1.11 | $0.84 | ||
| Q2 25 | $1.16 | $0.46 | ||
| Q1 25 | $0.75 | $0.24 | ||
| Q4 24 | $0.80 | $0.37 | ||
| Q3 24 | $0.87 | $0.23 | ||
| Q2 24 | $0.99 | $-1.84 | ||
| Q1 24 | $0.84 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.7M | $375.2M |
| Total DebtLower is stronger | $564.6M | $570.5M |
| Stockholders' EquityBook value | $1.4B | $865.9M |
| Total Assets | $2.4B | $2.2B |
| Debt / EquityLower = less leverage | 0.41× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $375.2M | ||
| Q3 25 | $54.4M | $340.1M | ||
| Q2 25 | $64.7M | $224.7M | ||
| Q1 25 | $57.5M | $99.0M | ||
| Q4 24 | $91.1M | $229.9M | ||
| Q3 24 | $73.7M | $103.8M | ||
| Q2 24 | $48.6M | $19.4M | ||
| Q1 24 | $48.9M | $8.0M |
| Q4 25 | $564.6M | $570.5M | ||
| Q3 25 | $201.2M | $577.2M | ||
| Q2 25 | $258.3M | $583.9M | ||
| Q1 25 | $266.9M | $590.5M | ||
| Q4 24 | $204.4M | $597.1M | ||
| Q3 24 | $223.3M | — | ||
| Q2 24 | $248.8M | — | ||
| Q1 24 | $266.8M | — |
| Q4 25 | $1.4B | $865.9M | ||
| Q3 25 | $1.3B | $890.7M | ||
| Q2 25 | $1.3B | $833.8M | ||
| Q1 25 | $1.2B | $789.2M | ||
| Q4 24 | $1.2B | $764.9M | ||
| Q3 24 | $1.1B | $732.5M | ||
| Q2 24 | $1.1B | $706.5M | ||
| Q1 24 | $1.0B | $856.2M |
| Q4 25 | $2.4B | $2.2B | ||
| Q3 25 | $1.9B | $2.2B | ||
| Q2 25 | $1.9B | $2.1B | ||
| Q1 25 | $1.9B | $2.0B | ||
| Q4 24 | $1.8B | $2.2B | ||
| Q3 24 | $1.7B | $2.1B | ||
| Q2 24 | $1.7B | $2.0B | ||
| Q1 24 | $1.7B | $2.2B |
| Q4 25 | 0.41× | 0.66× | ||
| Q3 25 | 0.15× | 0.65× | ||
| Q2 25 | 0.20× | 0.70× | ||
| Q1 25 | 0.22× | 0.75× | ||
| Q4 24 | 0.17× | 0.78× | ||
| Q3 24 | 0.19× | — | ||
| Q2 24 | 0.23× | — | ||
| Q1 24 | 0.26× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $97.2M | $114.1M |
| Free Cash FlowOCF − Capex | $89.5M | — |
| FCF MarginFCF / Revenue | 15.0% | — |
| Capex IntensityCapex / Revenue | 1.3% | — |
| Cash ConversionOCF / Net Profit | 1.60× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $227.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $97.2M | $114.1M | ||
| Q3 25 | $61.1M | $137.3M | ||
| Q2 25 | $59.7M | $137.2M | ||
| Q1 25 | $36.7M | $-117.5M | ||
| Q4 24 | $90.6M | $133.0M | ||
| Q3 24 | $68.8M | $91.8M | ||
| Q2 24 | $40.6M | $107.0M | ||
| Q1 24 | $31.3M | $-125.2M |
| Q4 25 | $89.5M | — | ||
| Q3 25 | $54.1M | — | ||
| Q2 25 | $52.4M | — | ||
| Q1 25 | $31.1M | — | ||
| Q4 24 | $82.1M | — | ||
| Q3 24 | $60.9M | — | ||
| Q2 24 | $24.8M | — | ||
| Q1 24 | $22.9M | — |
| Q4 25 | 15.0% | — | ||
| Q3 25 | 9.7% | — | ||
| Q2 25 | 9.3% | — | ||
| Q1 25 | 6.7% | — | ||
| Q4 24 | 17.4% | — | ||
| Q3 24 | 12.8% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 5.4% | — |
| Q4 25 | 1.3% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 1.8% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 3.2% | — | ||
| Q1 24 | 2.0% | — |
| Q4 25 | 1.60× | 3.39× | ||
| Q3 25 | 0.90× | 1.91× | ||
| Q2 25 | 0.84× | 3.49× | ||
| Q1 25 | 0.79× | -5.66× | ||
| Q4 24 | 1.81× | 4.36× | ||
| Q3 24 | 1.28× | 4.72× | ||
| Q2 24 | 0.67× | — | ||
| Q1 24 | 0.61× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FSS
| Vehiclesandequipment | $403.4M | 68% |
| Parts | $66.8M | 11% |
| Publicsafetyandsecurityequipment | $62.2M | 10% |
| Rentalincome | $19.0M | 3% |
| Industrialsignalingequipment | $18.2M | 3% |
| Other | $14.9M | 2% |
| Warningsystems | $12.6M | 2% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
